Mass Spectrometry Market by Technology (Hybrid Mass Spectrometry [Triple Quadrapole, Quadrapole TOF, and Fourier Transform Mass Spectrometry], Single Mass Spectrometry [Ion Trap, Quadrapole, and Time-of-Flight], and Other Mass Spectrometry) and Application (Pharmaceutical, Biotechnology, Industrial Chemistry, Environmental Testing, Food & Beverage Testing, and Other Applications): Global Opportunity Analysis and Industry Forecast, 2021–2030
- ALL4676836
- 194 Pages
- September 2021
- Diagnostic and Biotech
Mass spectrometry provides increased sensitivity over other analytical systems, owing to reduced background intrusion and superior specificity from characteristic fragmentation patterns to detect unknown compounds. In addition, it can also identify existence of suspected compound and data regarding molecular weight of the compound in the mixture, and provide data about isotopic abundance of elements and chemical data determined for a short term.
In addition to its use in the study of active genomics, metabolomics and proteomics, it is also used in many clinical settings (such as drug monitoring, abuse drugs and clinical toxicology), as well as in combination with other analytical techniques, e.g. chromatography (GC) or liquid chromatography (LC).
The market is expected to witness moderate growth during the forecast period, owing to technological advancement in mass spectrometry and increase in private funding and government grants for R&D in mass spectrometry. Stringent guidelines for food products have been set in food & beverage industry by regulating authorities, such as the Food and Drug Administration. Furthermore, advantages of mass spectrometry over other analytical technique are expected to fuel the market growth.
North America accounted for the highest share of $2,648.34 million in the mass spectrometry market in 2020, and is expected to reach $5871.02 million in 2030. Whereas Asia-Pacific is expected to grow at a highest CAGR of 9.2% in the study period.
The mass spectrometry market is segmented on the basis of technology, application, and region. By technology, it is categorized into hybrid mass spectrometry, single mass spectrometry, and other mass spectrometry. By application, it is classified into pharmaceutical, biotechnology, industrial chemistry, environmental testing, food & beverage testing, and other applications. Region wise, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA.
The prominent players in the market have adopted various strategies for increasing their market share. These include expansion of their geographical presence through collaborations and partnerships and increase in investment in developing long-acting and effective products with lower adverse effects. Major players operating in the mass spectrometry market include Agilent Technologies, Inc., Danaher Corporation, Waters Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc., Perkinelmer, Inc., Shimadzu Corporation., Kore Technologies, Ltd., Dani Instruments S.P.A., and Leco Corporation.
KEY BENEFITS FOR STAKEHOLDERS
• The study presents an in-depth analysis of the global mass spectrometry market along with the current trends and future estimations from 2021 to 2030 to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and recognition of the key players that can influence this market on a global & regional scale are provided in the report.
• Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
• The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Technology
o Hybrid Mass Spectrometry
• Triple Quadrupole (Tandem)
• Quadrupole TOF (Q-TOF)
• FTMS (Fourier Transform Mass Spectrometry)
o Single Mass Spectrometry
• Ion Trap
• Quadrupole
• Time-of-Flight (TOF)
o Other Mass Spectrometry
By Application
o Pharmaceutical
o Biotechnology
o Industrial Chemistry
o Environmental Testing
o Food & Beverage Testing
o Other Applications
By Region
o North America
• U.S.
• Canada
• Mexico
o Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
o Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Rest of Asia-Pacific
o LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Agilent Technologies Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
Perkinelmer Inc.
Shimadzu Corporation
Bruker Corporation
Waters Corporation
Kore Technologies, Ltd.
Dani Instruments S.P.A.
Leco Corporation
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Market share analysis
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Technological Advancement in Mass Spectroscopy
3.5.1.2.Growth in concerns for food and environmental welfare
3.5.1.3.Increase in use of Mass Spectrometry Techniques
3.5.2.Restraints
3.5.2.1.High cost of spectrometry equipment
3.5.2.2.Requirement of highly trained professionals
3.5.3.Opportunities
3.5.3.1.Miniaturization of mass spectroscopy devices
3.5.3.2.Untapped emerging markets
3.6.COVID-19 impact on the market
3.7.Recent Technological advancement
3.8.Average selling price of mass spectrometry devices
CHAPTER 4:MASS SPECTROMETRY MARKET, BY TECHNOLOGY
4.1.Overview
4.1.1.Market size and forecast
4.2.Hybrid mass spectrometry
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast of hybrid mass spectrometry, by Type
4.2.5.Market size and forecast of hybrid mass spectrometry, by Type
4.2.5.1.Triple Quadrupole (Tandem)
4.2.5.2.Market size and forecast
4.2.5.3.Market size and forecast
4.2.5.4.Quadrupole TOF (Q-TOF)
4.2.5.5.Market size and forecast
4.2.5.6.Market size and forecast
4.2.5.7.Fourier Transform Mass Spectrometry (FTMS)
4.2.5.8.Market size and forecast
4.2.5.9.Market size and forecast
4.2.5.9.1.FT-ICR MS
4.2.5.9.1.1.Market size and forecast
4.2.5.9.1.2.Market size and forecast
4.2.5.9.2.Orbitrap
4.2.5.9.2.1.Market size and forecast
4.2.5.9.2.2.Market size and forecast
4.3.Single mass spectrometry
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, of single mass spectrometry, by type
4.3.5.Market size and forecast, by technology
4.3.6.Ion Trap
4.3.6.1.Market size and forecast
4.3.6.2.Market size and forecast
4.3.7.Quadrupole
4.3.7.1.Market size and forecast
4.3.7.2.Market size and forecast
4.3.8.Time of Flight (TOF)
4.3.8.1.Market size and forecast
4.3.8.2.Market size and forecast
4.4.Other mass spectrometry
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:MASS SPECTROSCOPY MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.1.2.Market size and forecast
5.2.Pharmaceuticals
5.2.1.Market size and forecast, by region
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Biotechnology
5.3.1.Market size and forecast
5.3.2.Market size and forecast
5.3.3.Market analysis, by country
5.4.Security
5.4.1.Market size and forecast
5.4.2.Market size and forecast
5.4.3.Market analysis, by country
5.5.Industrial Chemistry
5.5.1.Market size and forecast
5.5.2.Market size and forecast
5.5.3.Market analysis, by country
5.6.Environmental Testing
5.6.1.Market size and forecast
5.6.2.Market size and forecast
5.6.3.Market analysis, by country
5.7.Food & beverage testing
5.7.1.Market size and forecast
5.7.2.Market size and forecast
5.7.3.Market analysis, by country
5.8.Forensic
5.8.1.Market size and forecast
5.8.2.Market size and forecast
5.8.3.Market analysis, by country
5.9.Clinical
5.9.1.Market size and forecast
5.9.2.Market size and forecast
5.9.3.Market analysis, by country
5.10.Other Applications
5.10.1.Market size and forecast
5.10.2.Market size and forecast
5.10.3.Market analysis, by country
CHAPTER 6:MASS SPECTROMETRY MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.1.2.Market size and forecast
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by country
6.2.2.1.U.S. mass spectroscopy market, by Technology
6.2.2.2.U.S. mass spectroscopy market, by Application
6.2.2.3.Canada mass spectroscopy market, by technology
6.2.2.4.Canada mass spectroscopy market, by application
6.2.2.5.Mexico mass spectroscopy market, by technology
6.2.2.6.Mexico mass spectroscopy market, by application
6.2.3.North America market size and forecast, by technology
6.2.4.North America market size and forecast, by application
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country
6.3.2.1.Germany mass spectroscopy market, by technology
6.3.2.2.Germany mass spectroscopy market, by application
6.3.2.3.France mass spectroscopy market, by technology
6.3.2.4.France mass spectroscopy market, by application
6.3.2.5.UK mass spectroscopy market, by technology
6.3.2.6.UK mass spectroscopy market, by application
6.3.2.7.Italy mass spectroscopy market, by technology
6.3.2.8.Italy mass spectroscopy market, by application
6.3.2.9.Spain mass spectroscopy market, by technology
6.3.2.10.Spain mass spectroscopy market, by application
6.3.2.11.Rest of Europe mass spectroscopy market, by technology
6.3.2.12.Rest of Europe mass spectroscopy market, by application
6.3.3.Europe market size and forecast, by technology
6.3.4.Europe market size and forecast, by application
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country
6.4.2.1.Japan mass spectroscopy market, by technology
6.4.2.2.Japan mass spectroscopy market, by application
6.4.2.3.China mass spectroscopy market, by technology
6.4.2.4.China mass spectroscopy market, by application
6.4.2.5.Australia mass spectroscopy market, by technology
6.4.2.6.Australia mass spectroscopy market, by application
6.4.2.7.India mass spectroscopy market, by technology
6.4.2.8.India mass spectroscopy market, by application
6.4.2.9.South Korea mass spectroscopy market, by technology
6.4.2.10.South Korea mass spectroscopy market, by application
6.4.2.11.Rest of Asia-Pacific mass spectroscopy market, by technology
6.4.2.12.Rest of Asia-Pacific mass spectroscopy market, by application
6.4.3.Asia-Pacific market size and forecast, by technology
6.4.4.Asia-Pacific market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country
6.5.2.1.Brazil mass spectroscopy market, by technology
6.5.2.2.Brazil mass spectroscopy market, by application
6.5.2.3.Saudi Arabia mass spectroscopy market, by technology
6.5.2.4.Saudi Arabia mass spectroscopy market, by application
6.5.2.5.South Africa mass spectroscopy market, by technology
6.5.2.6.South Africa mass spectroscopy market, by application
6.5.2.7.Rest of LAMEA mass spectroscopy market, by technology
6.5.2.8.Rest of LAMEA mass spectroscopy market, by application
6.5.3.LAMEA market size and forecast, by technology
6.5.4.LAMEA market size and forecast, by application
CHAPTER 7:COMPANY PROFILES
7.1.AGILENT TECHNOLOGIES INC.
7.1.1.Company overview
7.1.2.Operating business segments
7.1.3.Product portfolio
7.1.4.Business performance
7.1.5.Key strategic moves and developments
7.2.BRUKER CORPORATION
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments
7.3.DANAHER CORPORATION
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.4.HIDEN ANALYTICAL
7.4.1.Company overview
7.4.2.Operating business segments
7.4.3.Product portfolio
7.5.KORE TECHNOLOGY LTD.
7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Product portfolio
7.5.4.Key strategic moves and developments
7.6.PERKINELMER, INC.
7.6.1.Company overview
7.6.2.Operating business segments
7.6.3.Product portfolio
7.6.4.Business performance
7.7.LECO CORPORATION
7.7.1.Company overview
7.7.2.Operating business segments
7.7.3.Product portfolio
7.8.SHIMADZU CORPORATION
7.8.1.Company overview
7.8.2.Operating business segments
7.8.3.Product portfolio
7.8.4.Business performance
7.8.5.Key strategic moves and developments
7.9.THERMO FISHER SCIENTIFIC, INC.
7.9.1.Company overview
7.9.2.Operating business segments
7.9.3.Product portfolio
7.9.4.Business performance
7.9.5.Key strategic moves and developments
7.10.WATERS CORPORATION
7.10.1.Company overview
7.10.2.Operating business segments
7.10.3.Product portfolio
7.10.4.Business performance
7.10.5.Key strategic moves and developments
7.1.AGILENT TECHNOLOGIES INC.
7.1.1.Company overview
7.1.2.Operating business segments
7.1.3.Product portfolio
7.1.4.Business performance
7.1.5.Key strategic moves and developments
7.2.BRUKER CORPORATION
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments
7.3.DANAHER CORPORATION
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.4.HIDEN ANALYTICAL
7.4.1.Company overview
7.4.2.Operating business segments
7.4.3.Product portfolio
7.5.KORE TECHNOLOGY LTD.
7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Product portfolio
7.5.4.Key strategic moves and developments
7.6.PERKINELMER, INC.
7.6.1.Company overview
7.6.2.Operating business segments
7.6.3.Product portfolio
7.6.4.Business performance
7.7.LECO CORPORATION
7.7.1.Company overview
7.7.2.Operating business segments
7.7.3.Product portfolio
7.8.SHIMADZU CORPORATION
7.8.1.Company overview
7.8.2.Operating business segments
7.8.3.Product portfolio
7.8.4.Business performance
7.8.5.Key strategic moves and developments
7.9.THERMO FISHER SCIENTIFIC, INC.
7.9.1.Company overview
7.9.2.Operating business segments
7.9.3.Product portfolio
7.9.4.Business performance
7.9.5.Key strategic moves and developments
7.10.WATERS CORPORATION
7.10.1.Company overview
7.10.2.Operating business segments
7.10.3.Product portfolio
7.10.4.Business performance
7.10.5.Key strategic moves and developments
TABLE 01.GLOBAL MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 02.HYBRID MASS SPECTROMETRY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 03.HYBRID MASS SPECTROMETRY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 04.HYBRID MASS SPECTROMETRY MARKET, BY TYPE, 2020–2030 (VOLUME)
TABLE 05.SINGLE MASS SPECTROMETRY MASS SPECTROSCOPY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 06.SINGLE MASS SPECTROMETRY MASS SPECTROSCOPY MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 07.SINGLE MASS SPECTROMETRY MASS SPECTROSCOPY MARKET, BY TYPE, 2020-2030 (VOLUME)
TABLE 08.OTHERS MASS SPECTROSCOPY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 09.MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 10.MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020–2030 (VOLUME)
TABLE 11.MASS SPECTROMETRY MARKET FOR PHARMACEUTICAL, BY REGION, 2020–2030 ($MILLION)
TABLE 12.MASS SPECTROMETRY MARKET FOR PHARMACEUTICAL, BY REGION, 2020–2030 (VOLUME)
TABLE 13.MASS SPECTROMETRY MARKET FOR BIOTECHNOLOGY, BY REGION, 2020–2030 ($MILLION)
TABLE 14.MASS SPECTROMETRY MARKET FOR BIOTECHNOLOGY, BY REGION, 2020–2030 (VOLUME)
TABLE 15.MASS SPECTROMETRY MARKET FOR SECURITY, BY REGION, 2020–2030 ($MILLION)
TABLE 16.MASS SPECTROMETRY MARKET FOR SECURITY, BY REGION, 2020–2030 (VOLUME)
TABLE 17.MASS SPECTROMETRY MARKET FOR INDUSTRIAL CHEMISTRY, BY REGION, 2020–2030 ($MILLION)
TABLE 18.MASS SPECTROMETRY MARKET FOR INDUSTRIAL CHEMISTRY, BY REGION, 2020–2030 (VOLUME)
TABLE 19.ENVIRONMENTAL TESTING MASS SPECTROSCOPY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 20.ENVIRONMENTAL TESTING MASS SPECTROSCOPY MARKET, BY REGION, 2020–2030 (VOLUME)
TABLE 21.FOOD AND BEVERAGE TESTING MASS SPECTROSCOPY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 22.FOOD AND BEVERAGE TESTING MASS SPECTROSCOPY MARKET, BY REGION, 2020–2030 (VOLUME)
TABLE 23.MASS SPECTROMETRY MARKET FOR FORENSIC, BY REGION, 2020–2030 ($MILLION)
TABLE 24.MASS SPECTROMETRY MARKET FOR FORENSIC, BY REGION, 2020–2030 (VOLUME)
TABLE 25.CLINICAL MASS SPECTROSCOPY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 26.CLINICAL MASS SPECTROSCOPY MARKET, BY REGION, 2020–2030 (VOLUME)
TABLE 27.OTHER APPLICATION MASS SPECTROSCOPY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 28.OTHER APPLICATION MASS SPECTROSCOPY MARKET, BY REGION, 2020–2030 (VOLUME)
TABLE 29.MASS SPECTROSCOPY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 30.MASS SPECTROSCOPY MARKET, BY REGION, 2020-2030 (VOLUME)
TABLE 31.NORTH AMERICA MASS SPECTROSCOPY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32.U.S. MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 33.U.S. MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 34.CANADA MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020–2030
TABLE 35.CANADA MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 36.MEXICO MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020–2030
TABLE 37.MEXICO MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 38.NORTH AMERICA MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020–2030
TABLE 39.NORTH AMERICA MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 40.EUROPE MASS SPECTROSCOPY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 41.GERMANY MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020–2030
TABLE 42.GERMANY MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 43.FRANCE MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020–2030
TABLE 44.FRANCE MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 45.UK MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 46.UK MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 47.ITALY MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020–2030
TABLE 48.ITALY MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 49.SPAIN MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 50.SPAIN MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 51.REST OF EUROPE MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020–2030
TABLE 52.REST OF EUROPE MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 53.EUROPE MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020–2030
TABLE 54.EUROPE MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 55.ASIA-PACIFIC MASS SPECTROSCOPY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 56.JAPAN MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 57.JAPAN MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 58.CHINA MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020–2030
TABLE 59.CHINA MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 60.AUSTRALIA MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020–2030
TABLE 61.AUSTRALIA MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 62.INDIA MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 63.INDIA MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 64.SOUTH KOREA MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 65.SOUTH KOREA MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 66.REST OF ASIA-PACIFIC MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020–2030
TABLE 67.REST OF ASIA-PACIFIC MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020–2030
TABLE 68.ASIA-PACIFIC MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 69.ASIA-PACIFIC MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 70.LAMEA MASS SPECTROSCOPY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 71.BRAZIL MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 72.BRAZIL MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 73.SAUDI ARABIA MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 74.SAUDI ARABIA MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 75.SOUTH AFRICA MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 76.SOUTH AFRICA MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 77.REST OF LAMEA MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 78.REST OF LAMEA MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 79.LAMEA MASS SPECTROSCOPY MARKET, BY TECHNOLOGY, 2020-2030
TABLE 80.LAMEA MASS SPECTROSCOPY MARKET, BY APPLICATION, 2020-2030
TABLE 81.AGILENT: COMPANY SNAPSHOT
TABLE 82.AGILENT: OPERATING SEGMENTS
TABLE 83.AGILENT: PRODUCT PORTFOLIO
TABLE 84.AGILENT: KEY DEVELOPMENTS
TABLE 85.BRUKER: SNAPSHOT
TABLE 86.BRUKER: OPERATING SEGMENTS
TABLE 87.BRUKER: PRODUCT PORTFOLIO
TABLE 88.DANAHER: SNAPSHOT
TABLE 89.DANAHER: OPERATING SEGMENTS
TABLE 90.DANAHER: PRODUCT PORTFOLIO
TABLE 91.HIDEN ANALYTICAL : COMPANY SNAPSHOT
TABLE 92.HIDEN ANALYTICAL: OPERATING SEGMENTS
TABLE 93.HIDEN ANALYTICAL: PRODUCT PORTFOLIO
TABLE 94.KORE: COMPANY SNAPSHOT
TABLE 95.KORE: OPERATING SEGMENTS
TABLE 96.KORE: PRODUCT PORTFOLIO
TABLE 97.SHIMADZU: KEY DEVELOPMENTS
TABLE 98.PERKINELMER: COMPANY SNAPSHOT
TABLE 99.PERKINELMER: OPERATING SEGMENTS:
TABLE 100.PERKINELMER: PRODUCT PORTFOLIO
TABLE 101.LECO: COMPANY SNAPSHOT
TABLE 102.LECO: OPERATING SEGMENTS
TABLE 103.LECO: PRODUCT PORTFOLIO
TABLE 104.SHIMADZU: COMPANY SNAPSHOT
TABLE 105.SHIMADZU: OPERATING SEGMENTS
TABLE 106.SHIMADZU: PRODUCT PORTFOLIO
TABLE 107.SHIMADZU: KEY DEVELOPMENTS
TABLE 108.THERMO FISCHER: COMPANY SNAPSHOT
TABLE 109.THERMO FISCHER: OPERATING SEGMENTS
TABLE 110.THERMO FISCHER: PRODUCT PORTFOLIO
TABLE 111.THERMO FISCHER: KEY DEVELOPMENTS
TABLE 112.WATERS: COMPANY SNAPSHOT
TABLE 113.WATERS: OPERATING SEGMENTS
TABLE 114.WATERS: PRODUCT PORTFOLIO
TABLE 115.WATERS: KEY DEVELOPMENTS
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
